Xenical Research Today is a free monthly online journal that collates and summarizes the latest research about Xenical, including details on orlistat, side-effects, obesity, weight loss, dieting.

Volume 2 (2005), Issue 4 (April)

1. Effect of orlistat on cardiovascular disease risk in obese adults.
   Diabetes Obes Metab, 7(3): 254-62. [Abstract] [Full-text]
2. Pharmacological therapies for obesity.
   Gastroenterol Clin North Am, 34(1): 91-104. [Abstract] [Full-text]
3. Effect of orlistat on postprandial lipemia, NMR lipoprotein subclass profiles and particle size.
   Atherosclerosis, 180(1): 127-35. [Abstract] [Full-text]
4. Orlistat in responding obese type 2 diabetic patients: meta-analysis findings and cost-effectiveness as rationales for reimbursement in Sweden and Switzerland.
   Int J Obes (Lond), 29(5): 517-23. [Abstract] [Full-text]
5. Clinical evidence for drug treatments in obesity-associated hypertensive patients--a discussion paper.
   Methods Find Exp Clin Pharmacol, 27(2): 119-25. [Abstract] [Full-text]
6. Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels.
   Diabetologia, 48(4): 756-66. [Abstract] [Full-text]
7. A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin.
   Diabet Med, 22(5): 612-8. [Abstract] [Full-text]

© 2004-2008 Xenical Research Today. All Rights Reserved.